Veera Health is on a mission to help women lead healthier lives. Veera’s first offering is a digital therapeutics platform that helps women identify and navigate Polycystic Ovary Syndrome (PCOS), with a comprehensive offering of therapy, coaching and specialist support.
It’s estimated that 110 million women in India suffer from PCOS, yet only 30% of them have been clinically diagnosed. The illness is the most common cause of infertility in women, and can lead to diabetes, high-blood pressure, depression, anxiety, and even uterine cancer. Most women with PCOS spend years and hundreds of dollars on conventional PCOS treatments, yet continue to experience active symptoms throughout their lives.
Patients who sign up for Veera’s subscription program get access to a bespoke treatment plan, administered by a team of specialists including gynaecologists, nutritionists, dermatologists and mental health experts. Each plan is customised based on the patient’s medical history, past interventions and lifestyle preferences. A dedicated care manager also supports and tailors the experience for the patient through their journey, which can lead to meaningful and sustainable improvement in their quality of life.
Within a month of treatment, Veera’s PCOS members report significant improvements in their physical and mental health, including regularising their period, feeling less anxious and depressed, and losing weight, among other things. The startup’s vision is to close the gap in access to quality healthcare for women by providing scientific, progressive health care solutions.
Veera Health was founded in Mumbai by Shobhita and Shashwata Narain in August 2020. The sisters gained firsthand insight into the problem after Shobhita was diagnosed with PCOS a number of years ago. Shashwata has an MBA from Wharton and worked with consumer health companies at McKinsey, while Shobhita is a graduate of Tufts University and has worked with leading healthcare companies, such as GlaxoSmithKline, Accenture Life Sciences and UnitedHealth.
*Angel Investors: Benjamin Bryant, Ethan Perlstein, Holly Liu, Rohit MA, Taru Kapoor, Utsav Somani and Walter Chen